PATH trades at a discounted 4.37X forward P/S, making it look undervalued versus peers amid solid revenue and RPA growth.

UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

Mizuho Technology Conference 2025 Call June 11, 2025 2:05 PM ETCompany ParticipantsAshim Gupta - CFO & COOConference ...

UiPath (NYSE: PATH), the global leader in agentic automation, today announced the appointment of Simon Pettit as Area Vice President (AVP) for the UK & Ireland.

UiPath is shifting to what it calls Agentic Automation. The company's Q1 '26 call transcript and financial statements give us ...

UiPath (NYSE: PATH) has had to make a significant technological pivot. It began by outsourcing software services and transitioned into a leading robotic process automation (RPA) company. RPA uses ...

The revenue cycle management company partnered with UiPath to use AI to automate administrative tasks, like medical billing, ...